Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.


Journal Article (Review)

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

Full Text

Duke Authors

Cited Authors

  • Harskamp, RE; Zheng, Z; Alexander, JH; Williams, JB; Xian, Y; Halkos, ME; Brennan, JM; de Winter, RJ; Smith, PK; Lopes, RD

Published Date

  • December 2013

Published In

Volume / Issue

  • 96 / 6

Start / End Page

  • 2268 - 2277

PubMed ID

  • 24446561

Pubmed Central ID

  • 24446561

Electronic International Standard Serial Number (EISSN)

  • 1552-6259

Digital Object Identifier (DOI)

  • 10.1016/j.athoracsur.2013.07.093


  • eng

Conference Location

  • Netherlands